KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Return on Capital Employed (2020 - 2025)

Historic Return on Capital Employed for Royalty Pharma (RPRX) over the last 6 years, with Q3 2025 value amounting to 0.08%.

  • Royalty Pharma's Return on Capital Employed fell 100.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.08% for FY2024, which is 100.0% down from last year.
  • Latest data reveals that Royalty Pharma reported Return on Capital Employed of 0.08% as of Q3 2025, which was down 100.0% from 0.11% recorded in Q2 2025.
  • In the past 5 years, Royalty Pharma's Return on Capital Employed ranged from a high of 0.11% in Q1 2025 and a low of 0.02% during Q4 2022
  • Its 5-year average for Return on Capital Employed is 0.07%, with a median of 0.08% in 2021.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first tumbled by -700bps in 2021, then surged by 700bps in 2023.
  • Royalty Pharma's Return on Capital Employed (Quarter) stood at 0.08% in 2021, then crashed by -77bps to 0.02% in 2022, then soared by 390bps to 0.09% in 2023, then dropped by -18bps to 0.08% in 2024, then grew by 9bps to 0.08% in 2025.
  • Its last three reported values are 0.08% in Q3 2025, 0.11% for Q2 2025, and 0.11% during Q1 2025.